Compounds > desvenlafaxine-succinate

desvenlafaxine-succinate and 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile

desvenlafaxine-succinate has been researched along with 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile* in 1 studies

Other Studies

1 other study(ies) available for desvenlafaxine-succinate and 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile

ArticleYear
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Synapse (New York, N.Y.), 2018, Volume: 72, Issue:3

    SEP-227162 [R(-)-O-desmethylvenlafaxine] is an enantiomer of the venlafaxine metabolite O-desmethylvenlafaxine (ODV, Pristiq™, Wyeth). This study compared the serotonin transporter (SERT) occupancy achieved by SEP-227162 and ODV, at daily doses of 25, 50, 100, and 150 mg using [

    Topics: Adult; Aniline Compounds; Brain; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Serotonin and Noradrenaline Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sulfides; Young Adult

2018